Unicorn Fund Crosses 5% Threshold with 6.5883% Stake Acquisition in Accretion Nutraveda Limited

Accretion Nutraveda Limited has announced that Unicorn Fund has crossed the 5% shareholding threshold by acquiring 477000 equity shares, representing 6.5883% of the company's total paid-up equity share capital. The disclosure was made on February 17, 2026, pursuant to Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Acquisition Details The acquisition represents a significant milestone as Unicorn Fund had no prior holdings in Accretion Nutraveda Limited before this transaction. The fund's shareholding increased from zero to 6.5883% through this acquisition, thereby triggering mandatory disclosure requirements under SEBI regulations. Parameter: Details Acquirer: Unicorn Fund Shares Acquired: 477000 Percentage Acquired: 6.5883% Previous Holding: NIL Post-Acquisition Holding: 6.5883% Mode of Acquisition Unicorn Fund acquired the equity shares through multiple channels over a two-day period in February 2026: IPO Participation: 471000 shares through public issue 466000 shares via Anchor Application on February 4, 2026 5000 shares through QIB Ex Anchor on February 4, 2026 Secondary Market Purchases: 6000 shares 1000 shares on February 4, 2026 5000 shares on February 5, 2026 Regulatory Compliance The company received the revised disclosure from Unicorn Fund via email on February 16, 2026, and subsequently filed the mandatory disclosure with BSE Limited. Unicorn Fund does not belong to the promoter or promoter group of Accretion Nutraveda Limited, classifying this as an external investor acquisition. Compliance Aspect: Details Regulation: SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Threshold Crossed: 5% Stock Exchange: BSE Limited Scrip Code: 544694 Disclosure Date: February 17, 2026 The acquisition demonstrates investor confidence in Accretion Nutraveda Limited, with Unicorn Fund making a substantial investment through both primary and secondary market channels. The company has fulfilled all regulatory disclosure requirements and informed BSE Limited of this significant shareholding change. Accretion Nutraveda Limited has announced that Unicorn Fund has acquired a significant stake in the company, crossing the regulatory disclosure threshold of 5%. The acquisition represents a notable investment by the fund in the nutrition and wellness sector company. Acquisition Details Unicorn Fund acquired 478000 equity shares of Accretion Nutraveda Limited, representing 6.6022% of the company's total paid-up equity share capital. This acquisition marks the fund's entry into the company as a substantial shareholder, having held no previous stake in the organization. Parameter Details Shares Acquired 478000 Percentage Stake 6.6022% Previous Holding NIL Acquirer Category Non-Promoter Transaction Structure and Timeline The acquisition was executed through multiple channels over two days in February 2026. The fund participated in the company's Initial Public Offering (IPO) while also making strategic purchases from the secondary market. Acquisition Breakdown: IPO Participation: 471000 shares Anchor allocation: 466000 shares on February 4, 2026 QIB Ex Anchor: 5000 shares on February 4, 2026 Secondary Market Purchases: 7000 shares February 4, 2026: 1000 shares February 5, 2026: 6000 shares Regulatory Compliance The disclosure was made pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Under these regulations, any acquisition that results in holding 5% or more of a company's equity shares requires mandatory disclosure to stock exchanges. Regulatory Aspect Details Threshold Crossed 5% Final Holding 6.6022% Regulation SEBI SAST Regulation 29(1) Stock Exchange BSE Limited Fund Authorization The acquisition was authorized by Mr. Viren S Patel, serving as Designated Partner and Investment Manager for Unicorn Fund. The formal disclosure documentation was completed and submitted to BSE Limited on February 5, 2026, ensuring compliance with regulatory timelines. Accretion Nutraveda Limited, formerly known as Accretion Nutraveda Private Limited, operates in the nutrition and wellness sector. The company's shares are listed on BSE Limited under scrip code 544694. This acquisition represents Unicorn Fund's confidence in the company's growth prospects and market position within the nutraceutical industry. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.